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REVIEW
Hematological disorders at birth in complicated monochorionic twins
Lianne Verbeeka, Femke Slaghekkeb, Marieke Suetersb, Johanna M. Middeldorpb, Frans J. Klumperb,
Monique C. Haakb, Dick Oepkesb and Enrico Lopriorea
aDivision of Neonatology, Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands; bDepartment of Obstetrics, Leiden
University Medical Center, Leiden, The Netherlands
ABSTRACT
Introduction: Monochorionic twins are at risk of severe complications including twin-twin transfusion
syndrome (TTTS), twin anemia-polycythemia sequence (TAPS) and acute peripartum TTTS. The patho-
physiology is based on inter-twin blood transfusion through placental vascular anastomoses.
Areas covered: This review focuses on the incidence, management and outcome of neonatal hema-
tological complications at birth in TTTS, TAPS and acute peripartum TTTS.
Expert commentary: Hematological disorders are often present at birth in monochorionic twins and
include acute or chronic anemia, polycythemia and thrombocytopenia. Routine measurement of
complete blood counts in all complicated monochorionic twins is strongly recommended. Increased
awareness on these disorders and correct diagnostic tests will lead to prompt and adequate manage-
ment at birth.
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Twin pregnancies are associated with higher morbidity and
mortality rates compared to singletons. This increased risk is
partly due to premature birth and lower birth weight, but
chorionicity is also an important risk factor [1,2].
Monochorionic (MC) twins carry a higher risk for severe com-
plications than dichorionic (DC) twins due to their unique
placenta architecture. In DC twins, each fetus has its own
placenta while in MC twins both fetuses share a single pla-
centa. These MC placentas are characterized by the presence
of vascular anastomoses, allowing blood to flow between the
fetuses during pregnancy or during delivery [3,4]. Different
types of anastomoses are known. Artery-to-vein (AV) anasto-
moses, or also called ‘deep anastomoses,’ are mainly respon-
sible for complications, since blood flow through AV
anastomoses is unidirectional from the artery of one twin to
the vein of the co-twin. Arterio-arterial (AA) anastomoses are
superficial anastomoses that allow bidirectional blood flow.
AA anastomoses are detected in the majority of uncompli-
cated MC placentas and are considered to have a protective
effect against unbalanced inter-twin blood flow. Veno-venous
(VV) anastomoses are also superficial anastomoses. However,
the clinical consequences of VV anastomoses are not well
known and association with increased risk of morbidity and
mortality has been reported [5].
In the majority of cases, inter-twin blood flow is in balance,
not causing complications. However, in up to 20% of cases,
net inter-twin blood flow is unbalanced and may lead to
disorders such as twin–twin transfusion syndrome (TTTS) or
twin anemia–polycythemia sequence (TAPS) during
pregnancy. In addition, acute inter-twin blood transfusion
can occur during delivery. The differences between TTTS,
TAPS, and acute peripartum TTTS are shown in Table 1.
In this review, we focus on the hematological disorders in
MC twin neonates with various forms of inter-twin blood
transfusion such as TTTS and TAPS. In addition, we will discuss
the incidence, risks, and management of anemia, polycythe-
mia, and thrombocytopenia in these high-risk twins. Given the
paucity of published data on hematological complications at
birth, we evaluated the incidence and severity of these com-
plications in MC twins delivered at our center. Since 2002, we
routinely perform a complete blood count in all MC twins
admitted to our neonatal ward (standard of care), and infor-
mation of the need for blood transfusion due to anemia or
partial exchange transfusion (PET) due to polycythemia is
prospectively recorded in a dedicated database.
Based on our clinical experience and in agreement with the
literature, white blood cell disorders are not a relevant clinical
complication in MC twins at birth. Information on leukocyto-
penia and on its possible clinical implications will not be a part
of this review.
2. Twin–twin transfusion syndrome (TTTS)
TTTS is a severe complication caused by chronic unbalanced
inter-twin blood transfusion through placental anastomoses
that occurs in 10% of MC twins [6,7]. Diagnosis is based on
prenatal ultrasound detection of large inter-twin amniotic fluid
difference, so called twin oligo-polyhydramnios sequence
(TOPS). Oligohydramnios in the donor is defined as a deepest
vertical pocket of amniotic fluid ≤2 cm, and polyhydramnios in
CONTACT Lianne Verbeek l.i.verbeek@lumc.nl Department of Pediatrics, Leiden University Medical Center J6-S, Albinusdreef 2, 2333 ZA. Leiden, The
Netherlands
EXPERT REVIEW OF HEMATOLOGY, 2017
VOL. 10, NO. 6, 525–532
https://doi.org/10.1080/17474086.2017.1324290
© 2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/),
which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
the recipient is defined as ≥8 cm within the first 20 weeks of
gestation or, according to the Eurofoetus criteria, ≥10 after
20 weeks of gestation [8]. A classification system was defined
by Quintero et al. [9]. The five stages are based on ultrasound
findings and Doppler velocimetry in the umbilical artery and the
umbilical vein. In all stages, TOPS is present. In stage I, the
bladder of the donor is still visible and the Doppler measure-
ments in both twins are normal. In stage II is the bladder of the
donor twin not visible anymore. In stage III, the donor’s bladder is
not visible and Doppler measurements are abnormal consisting
of absent/reversed end-diastolic velocity in the umbilical artery
or pulsatile flow in the umbilical vein in either fetuses. In the
‘atypical’ presentation of stage III, the bladder of the donor twin
is visible. In stage IV, one of the fetuses shows signs of hydrops
(mainly due to progressive cardiac failure). Stage V is character-
ized by intrauterine fetal demise of one or both fetuses.
The reported mortality rate in TTTS is very high (up to
73–100%) if left untreated [10]. Several antenatal treatment
options have been proposed during the past decades including
serial amnioreduction and fetoscopic laser surgery.
Amnioreduction is mainly a symptomatic treatment aiming to
treat the severe polyhydramnios in the recipient and reduce the
risk of premature delivery due to premature uterine distension,
contractions, or rupture of the membranes. Fetoscopic laser
surgery is the only causal treatment and aims to separate the
fetal circulations by coagulating all vascular anastomoses. A
randomized controlled trial proved that fetoscopic laser coagu-
lation results in higher survival rates and lower rates of neuro-
logic complications compared to amnioreduction [8].
2.1. Hematological disorders in TTTS
Hematological disorders in TTTS are already present antena-
tally. Some small studies examining fetal blood samples
showed that hematocrit, hemoglobin, and red blood cell
count levels are significantly lower in donor twins compared
to recipient twins [11,12]. In the past, large inter-twin differ-
ence in hemoglobin level at birth was considered diagnostic
for TTTS, often in combination with large inter-twin birth
weight discordances [13,14]. These criteria were abandoned
several decades ago, when it became clear that birth weight
and/or hemoglobin discordance are relatively common in MC
twins and that the prenatal criteria described above were
more useful to reach the diagnose of TTTS [15]. Donors in
TTTS may be severely anemic, whereas recipients may suffer
from severe hyperviscosity–polycythemia. In addition, several
case reports described vascular ischemic limb necrosis in reci-
pient twins, mainly in TTTS cases not treated with laser sur-
gery. The pathogenesis of limb necrosis is related to vascular
occlusion due to severe hyperviscosity and polycythemia and
secondary thrombosis, though hypertension and vasoconstric-
tion may also play a role [16,17].
At birth, neonates with TTTS often have hematological
disorders. The presence of hematologic complications and
inter-twin hemoglobin differences depends on the type of
antenatal treatment. In TTTS twins treated conservatively
(expectant management or serial amnioreduction), we found
that donors had a significant lower hemoglobin level at birth
compared to recipient twins. Median inter-twin hemoglobin
difference was 3.6 (1.6–6.0) g/dL. In contrast, in TTTS treated
with laser coagulation surgery, no significant difference in
hemoglobin levels was found [18].
Between 2002 and 2016, 62 TTTS twin pairs treated con-
servatively were delivered at our center. Due to missing values
and fetal or postnatal demise, the total number of recruited
twins and described twins varies between the different vari-
ables throughout this article. For each variable, the number of
twins with complete information was stated as total number
(n). The percentage of donors requiring a blood transfusion on
day 1 was 33% (14 of a total twin number of 43). Recipients
required a PET at birth in 24% (10/42). In the group of TTTS
twin pairs treated with complete laser coagulation and born
alive at our center, only 5% (13/251) of the ex-donors needed
a blood transfusion on day 1 and 1% (2/252) of the recipients
needed a PET (Table 2). Coagulation of all vascular anasto-
moses thus allows re-equilibration of the hematological imbal-
ance: After surgery, the hemoglobin level in the donor twin
will gradually increase due to cessation of blood loss, while
the hemoglobin level in the recipient twin will gradually
decrease as transfusion from its co-twin stops. However, feto-
scopic laser surgery is not always complete and (small) resi-
dual anastomoses may be left patent in up to a third of cases,
allowing persistence of TTTS or development of post-laser
TAPS (see next paragraph) [19]. In both the situations, large
inter-twin hemoglobin differences may still be found at birth
[20]. Between 2002 and 2016, 47 TTTS twin pairs were treated
with laser coagulation surgery and had residual anastomoses,
resulting in post-laser TAPS or recurrent TTTS. The percentage
of donors requiring a blood transfusion on day 1 was 55% (26/
47) and the percentage of recipients requiring a PET on day 1
Table 1. Differences between TTTS, TAPS, and acute TTTS.
Pathogenesis Timing of diagnosis and criteria Hematological disorders at birth
TTTS Chronic inter-twin transfusion through
anastomoses, usually during second
trimester of pregnancy
Antenatal; oligo-polyhydramnios sequence on
ultrasound
Inter-twin Hb discordance might occur
depending on antenatal treatment
TAPS Chronic inter-twin transfusion through
small (diameter <1 mm)
anastomoses, may occur during
second or third trimester of
pregnancy
Antenatal; discordant MCA-PSV values on
Doppler ultrasound, or postnatal; inter-twin
Hb discordance and large inter-twin
reticulocyte count ratio or small
AV-anastomoses <1 mm
Large inter-twin Hb difference (>8 g/dL)
Reticulocytosis in the donor and inter-twin
reticulocyte count ratio >1.7
Polycythemia in the recipient
Increased risk of thrombocytopenia in
recipient
Acute peripartum TTTS Acute inter-twin transfusion through
anastomoses during delivery
Postnatal; inter-twin Hb discordance without
inter-twin difference in reticulocyte count
Large inter-twin Hb difference >8 g/dL
No reticulocytosis in donor
Reticulocyte count ratio <1.7
Hb: Hemoglobin; TTTS: twin–twin transfusion syndrome; TAPS: twin anemia–polycythemia sequence.
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was 35% (16/46) (Table 2). As shown in the recently published
Solomon trial, the use of the Solomon laser technique (in
which a laser coagulation line is drawn along the vascular
equator) reduces the risks of post-laser TAPS or recurrent
TTTS from 21% (in the classic selective laser technique) to
4% in the Solomon technique [21].
Since presence of residual anastomoses may not always be
predicted antenatally, we strongly advise to measure hemo-
globin levels in TTTS twins at birth in all cases, whether treated
with laser surgery or not. Blood transfusion in donors and PET
in recipients may be required depending on the local, national
protocols for the management of anemia and polycythemia.
Figure 1 shows the incidence of anemia and polycythemia in
complicated MC twins delivered at our center between 2002
and 2016.
3. Twin anemia-polycythemia sequence (TAPS)
TAPS is a newly described form of chronic inter-twin blood
transfusion leading to anemia in the donor and polycythemia
in the recipient, without signs of oligo-polyhydramnios as
seen in TTTS. TAPS is caused by the presence of only few
small placental vascular anastomoses (diameter <1 mm).
These minuscule anastomoses allow slow transfusion of
blood from one twin to the other, without the hemodynamic
imbalance and discordant fetal urine production, as in TTTS.
In a few cases, we were able to measure the blood flow over
the anastomoses and found it be approximately 5–10 ml/
24 h [22].
Two types of TAPS have been described. The form which
occurs sometimes after laser treatment for TTTS, ‘post-laser
TAPS,’ was first described in 2006 by Robyr et al. [23]. The
‘spontaneously’ occurring form of TAPS, as well as the acro-
nym TAPS, was first described in 2007 by Lopriore et al. [24].
The close relationship between minuscule anastomoses and
TAPS was then clearly established. The incidence of sponta-
neous TAPS is 3–5% of MC twin pregnancies while post-laser
TAPS can occur in 2–16% of TTTS twins after laser surgery
[23,25–27].
TAPS can be diagnosed antenatally and postnatally. The
antenatal diagnosis depends on Doppler ultrasound abnorm-
alities and includes increased middle cerebral artery peak
Table 2. Hemoglobin levels and reticulocyte counts at birth, and presence of anemia or polycythemia.
Hb level (g/dL) Reticulocyte count (g/dL) Anemia
n (%)a
Polycythemia
n (%)bDonors Recipients Donors Recipients






































































Values given as mean ± SD.
aAnemia at birth defined as low hemoglobin level requiring a blood transfusion on day 1.
bPolycythemia at birth defined as an increased hematocrit requiring a partial exchange transfusion on day 1.
N refers to numbers of twin pairs; n refers to number of neonates; TTTS: twin–twin transfusion syndrome.
Figure 1. Anemia (needing blood transfusion) and/or polycythemia (needing PET) at birth in complicated monochorionic twins.
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systolic velocity (MCA-PSV) of >1.5 multiples of the median
(MoM), predicting anemia in the donor, and reduced MCA-PSV
of <1.0 MoM in the recipient, a sign of polycythemia. Absence
of TOPS is a conditio sine qua non, since the presence of TOPS
is pathognomonic for TTTS [23,25,28]. The postnatal diagnosis
is made based on hematological criteria at birth. Several defi-
nitions for postnatal TAPS have been proposed, such as a
hemoglobin level <11 g/dL in the anemic twin and >20 g/dL
in the polycythemic twin, by Lewi et al. [6]. The most impor-
tant limitation of this definition is the fact that it does not take
into account that hemoglobin is known to increase linearly
with gestation [29,30]. Currently accepted postnatal criteria
include an inter-twin hemoglobin difference >8.0 g/dL and
at least one of the following: reticulocyte count ratio >1.7 or
placenta with only small (diameter <1 mm) placental vascular
anastomoses [23,25]. Reticulocyte count ratio can be mea-
sured by dividing the reticulocyte count of the donor with
those of the recipient. Detection of the minuscule anasto-
moses can only accurately be assessed by careful placental
injections studies using color dye.
In analogy with TTTS, a TAPS staging system has been
developed, subdivided in an antenatal and postnatal classifi-
cation. In the antenatal stage I and II, there are no signs of
fetal compromise except for MCA-PSV in the donor >1.5 MoM
in stage I and >1.7 in stage II and MCA-PSV in the recipient
<1.0 MoM in stage I and <0.8 MoM in stage II. In stage III, the
MCA-PSV is as in stage I or II and besides, the donor suffers
from cardiac compromise defined as critically abnormal flow
(absent or reversed end-diastolic flow in umbilical artery, pul-
satile flow in the umbilical vein, increased pulsatility index, or
reversed flow in ductus venosus). In stage IV, hydrops of the
donor is seen due to severe anemia and in stage V intrauterine
demise of one or both fetuses occurred. The postnatal classi-
fication is based on the inter-twin hemoglobin difference
starting at >8.0 g/dL in stage I, >11.0 g/dL in stage II,
>14.0 g/dL in stage III, >17.0 g/dL in stage IV, and >20.0 g/
dL in stage V [25].
The optimal antenatal treatment for TAPS is still not clear.
Although the pathophysiology of TAPS is also based on vas-
cular anastomoses and fetoscopic laser surgery or delivery
would be the only curative treatment, this is more challenging
than in TTTS because of the absence of the polyhydramnios–
oligohydramnios situation. The uterus is less distended, mak-
ing insertion of instruments more risky, and the wavering
inter-twin membrane prevents visualization of vessels behind
it. In addition, the anastomoses in TAPS are minuscule and
therefore more difficult to detect during fetoscopic laser coa-
gulation. Moreover, laser surgery is associated with complica-
tions as premature rupture of the membranes, disruption of
the inter-twin membrane, and fetal demise. Besides (repeat)
fetoscopic laser coagulation, possible management options
are induction of labor, intrauterine transfusion (IUT) (intravas-
cular or intraperitoneal) in the donor with or without PET in
the recipient, selective termination, pregnancy termination, or
expectant management since spontaneous resolution has
been described as well. Some authors describe a combination
of treatments [25,31–35]. Prevention of post-laser TAPS can be
successfully achieved by using the Solomon laser coagulation
technique, as previously mentioned [21].
3.1. Hematological disorders in TAPS
Neonates with TAPS have mainly short-term hematologic
complications. Donor twins have chronic anemia with highly
increased reticulocyte counts, reflecting chronic blood loss. A
blood transfusion is often needed in the first 24 h of birth in
57–80% of cases [36–39]. However, given the chronic nature of
the anemia, immediate transfusion at birth or in the delivery
room is not necessary. In contrast, recipients may be severely
polycythemic and require PET in 40–71% of cases [36–39].
Severe hyperviscosity in recipients may lead to necrosis of
the skin and multiple limb ischemia or severe cerebral injury
[23,40]. Prompt detection and treatment at birth with PET is of
paramount importance. Some studies report blood transfusion
in the donor with the blood concomitantly obtained from the
polycythemic co-twin during PET [41]. Between 2002 and
2016, 27 spontaneous TAPS twin pairs were delivered in our
center. A blood transfusion on day 1 was required in 83% (19/
23) of the donor twins and 54% (13/24) of the recipient twins
required PET on day 1 (see Table 2 and Figure 1).
Thrombocytopenia (platelet count <150 × 109/L) occurs
more often in twins affected by TAPS compared to MC twins.
In a study of Lopriore et al. with 38 TAPS neonates, 1 recipient
with severe thrombocytopenia required a platelet transfusion
at birth. However, thrombocytopenia in TAPS is mostly self-
limiting [37]. Polycythemia is generally associated with throm-
bocytopenia [42]. Recipient twins are by definition polycythe-
mic and several studies reported lower platelet count in
recipients than in donors. Platelet count in recipient twins is
also negatively correlated to hemoglobin level at birth. Low
platelet count in polycythemic recipients might be explained
by impaired production secondary to tissue hypoxia, slow
spleen blood flow, and decreased plasma fraction with normal
concentrations [37,42].
4. Acute peripartum TTTS
Acute peripartum TTTS, sometimes referred to as ‘acute peri-
natal TTTS,’ is a rare form of inter-twin transfusion which may
occur due to acute shifts of blood between the two fetuses
during delivery. Knowledge on acute peripartum TTTS is lim-
ited and mainly based on casuistic reports and small, often
incomplete, cases series. The incidence is reported to range
from 1.5% to 2.5% in all MC twins [39,43,44]. The pathogenesis
is not clear and several hypothetic mechanisms have been
suggested. Reports suggest that acute peripartum TTTS may
be due to acute shifts of relatively large volumes of blood
from one twin to the other due to blood pressure differences
following uterine contractions or changes in fetal positions.
This is likely only possible through large AA or VV anasto-
moses. Mode of delivery and birth order could play a role,
since acute peripartum TTTS mostly occurs in twins born
vaginally and first-born twins are usually the ones with the
lower hemoglobin levels [44–47]. However, Mabuchi et al.
described five twins with acute peripartum TTTS born through
emergency cesarean section [39]. The diagnostic criteria for
acute peripartum TTTS are not clear and most reports use a
hemoglobin difference of more than 8 g/dL at birth in the
absence of TTTS or TAPS. Characteristically, twins with acute
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peripartum TTTS have a large color difference at birth and
large differences in hemoglobin levels and may thus resemble
cases with TAPS. Differentiation with TAPS can be made after
birth by measuring reticulocyte counts. In acute peripartum
TTTS, the reticulocyte count in the donor twins should be low
since increased erythropoiesis (and increased reticulocytes)
cannot occur in a short instant of time. In contrast in TAPS,
the donor twin always has a highly increased reticulocyte
count as a sign of chronic blood loss.
In addition, placental injection studies should also be per-
formed to help differentiate between the various complica-
tions. As mentioned above, acute shifts of blood between two
fetuses could only occur through superficial AA or VV anasto-
moses. These superficial anastomoses have a large diameter
and a low vascular resistance allowing rapid shifts of blood.
The absence of such large anastomoses should prompt inves-
tigators to envisage other causes. In most case, reports on
acute peripartum TTTS published in the past, measurement of
reticulocyte count or placental injection studies were not
performed hampering the differentiation with TAPS. We
hypothesize that most case reports of acute peripartum TTTS
in the past were probably TAPS cases, wrongly diagnosed due
to limited knowledge on TAPS.
Importantly, the donor twin in acute peripartum TTTS may
suffer from acute blood loss resulting in severe anemia and
hypovolemic shock. Management in case of acute peripartum
TTTS warrants prompt use of volume expanders and blood
transfusion in the donor twin, and possibly PET in the recipient
in case of polycythemia hyperviscosity. The donor twins
described in the case reports needed a blood transfusion in
33–40% of cases and recipients needed PET in 17–20% [39,44].
Between 2002 and 2016, 12 twin pairs with acute peripartum
TTTS were born at our center. In 27% (3/11) of the donors, a
blood transfusion was needed and in 27% (3/11) of the reci-
pients, a blood transfusion was needed (see Table 2 and
Figure 1).
5. Acute perimortem TTTS due to acute
exsanguination
Acute perimortem TTTS occurs during intrauterine fetal
demise of a co-twin and is due to acute exsanguination from
the surviving twin into the low-pressure circulation of the
dying co-twin who fails to maintain its sympathetic tone. It is
thought to be mainly mediated by large, superficial, AA, or VV
anastomoses, since these anastomoses have a low resistance
and therefore allow blood to flow rapidly from one twin to the
other [48]. The acute hypovolemic shock and ischemia occur
so rapidly that treatment using a blood transfusion practically
always comes too late. Similarly, an emergency cesarean sec-
tion would require detecting the impending fetal demise as it
happens or very shortly after a rare situation. Whether IUT at a
later stage, when the surviving fetus remains anemic as diag-
nosed by MCA Doppler measurements, is useful is unclear. The
acute blood loss during the process of demise of the co-twin
likely stops quickly after its death. The resulting anemia cannot
be reversed by a late blood transfusion. The resulting anemia
likely improves by itself; however, this may take several days
or more. Transfusion may help restore normal hemoglobin
levels. More data on this situation are needed, and several
studies are on their way [48–50].
Acute exsanguination may also occur in specific conditions
such as in cases of ruptured vasa previa, one of the most
dramatic complications in MC twins. In the literature, 10
cases of MC twins with antenatally undetected ruptured vasa
previa and a velamentous cord insertion are described, with a
perinatal mortality rate of 55% [51].
A velamentous umbilical cord insertion is characterized by
membranous umbilical vessels at the placental insertion site. In
vasa previa, one or more fetal blood vessels run through the
amniotic membranes and cross or run near the external orifice of
the uterus [52]. Rupture of the membranes can lead to tearing of
these vessels and thereby cause acute fetal exsanguination.
Vasa previa is more common in placenta previa, conception
by assisted reproductive technologies, velamentous cord
insertion, and bilobed placenta [53]. Velamentous cord inser-
tion with vasa previa occurs more frequently in twin pregnan-
cies compared to singletons, with a higher prevalence in MC
twins than in DC twins [54]. In singletons or DC twins, rupture
of vasa previa can result in acute exsanguination and subse-
quently severe hypoxic–ischemic injury. In MC twins, due to
placental vascular anastomoses, rupture of vasa previa of one
of the twins can lead to exsanguination in both twins. This can
lead to hypovolemic shock and severe anemia requiring
prompt management with rapid iv bolus and blood transfu-
sion. Hypovolemic shock can lead to hypoxic–ischemic injury
mainly to the brain and kidneys and result in severe cerebral
injury or terminal kidney failure or double fatal outcome.
Prevention is the key to reduce the risks of acute exsanguina-
tion and is based on prenatal detection of vasa previa and
delivery through cesarean section before spontaneous rupture
of membranes [55].
6. Uncomplicated MC twins
Various studies showed that hemoglobin levels are higher in
term and preterm neonates born after vaginal delivery com-
pared to neonates delivered through cesarean section [56–
58]. These studies also show that hemoglobin levels are often
higher in second-born twins compared to their first-born co-
twin. The cause of this discordance may be due to various
reasons. First, higher hemoglobin levels in second borns may
result from unbalanced inter-twin transfusion during delivery.
It might be that due to differences in pressure gradients and
uterine contractions, relatively more blood flows from the
first-born twin to the second-born twin. Another hypothesis
could be that after delivery and umbilical cord clamping of
the first twin, the yet unborn second twin receives blood
from both placental shares through placento-fetal transfu-
sion. An alternative explanation could be that the timing of
umbilical cord clamping differs in the first and second twin.
Since delayed cord clamping (>30 s) leads to higher hemo-
globin levels due to increased placento-fetal transfusion, it
might be that the umbilical cord of the first-born twin is
clamped relatively early compared to the second-born co-
twin. In this case, we theorize that once the first twin is born,
obstetricians may tend to clamp the cord relatively early in
order to focus on the delivery of the second twin. The
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obstetrician may leave a longer interval for clamping the
cord of the second twin, resulting in a higher hemoglobin
level in the second twin [59,60].
Stagnati et al. describe that third-trimester inter-twin MCA-
PSV discrepancy in uncomplicated MC is associated with selec-
tive intrauterine growth restriction (sIUGR) at birth and an
inter-twin birth weight discrepancy of >25% [26]. MCA-PSV
values are highly correlated with hemoglobin levels [61]. One
would therefore also expect to find hemoglobin discordances
at birth in sIUGR twins. However, hemoglobin levels were not
reported in this study. In another small group of sIUGR twins,
Chang et al. found increased umbilical plasma erythropoietin
concentrations. Increased levels of erythropoietin reflect
hypoxia and increased hemoglobin levels are expected.
However, erythropoietin ratio was not paralleled by alterations
in hemoglobin levels [62]. Further research to investigate
hemoglobin levels in MC twins with sIUGR in a larger cohort
is warranted.
7. Expert commentary
MC twins are at risk for severe complications including TTTS,
acute peripartum TTTS, and TAPS. The pathophysiology of
these complications is based in all cases on the presence of
placental vascular anastomoses. Differentiation between
these various disorders is important. TTTS and TAPS are
based on chronic unbalanced inter-twin blood transfusion
during pregnancy (usually second trimester), while acute
peripartum TTTS is based on acute inter-twin blood transfu-
sion during delivery. Untreated or incompletely treated TTTS
often results in hematological complications in neonates.
After complete laser surgery, hematological complications
are rare. In TAPS and in acute peripartum TTTS, large inter-
twin hemoglobin differences are found and measurement of
reticulocyte counts is of paramount importance to differenti-
ate between the two disorders. In addition, TAPS recipient
twins are also at risk for thrombocytopenia probably due to
hyperviscosity.
In uncomplicated vaginally delivered MC twins, the second-
born twins often have a higher hemoglobin level than the
first-born co-twins. Whether this is due to vascular anasto-
moses in the placenta or differences in umbilical cord clamp-
ing interval is not yet known. Lastly, the most dramatic
hematologic complication in MC twins occurs in case of rup-
ture of vasa previa. Acute exanguination in both twins due to
transfusion through vascular anastomoses may occur, which
may lead to a double fatal outcome. Increased knowledge and
awareness of the characteristic placental angioarchitecture
and associated complications is important for prompt and
adequate management and to reduce the risk of adverse out-
come in MC twins.
8. Five-year view
Improved antenatal management in complicated MC twins
with TTTS or TAPS has led to an increased perinatal survival.
Attention is now shifting toward postnatal morbidity in survi-
vors, including hematological complications after delivery.
Despite the improvements in perinatal care in complicated
MC twins, hematological disorders are frequently detected.
Given the important effect of timing of cord clamping on
hemoglobin values at birth, more research is needed to
study this effect in specific subgroups of MC twins. Delayed
cord clamping could be beneficial to reduce the risk in anemia
in donors, and early cord clamping to reduce the risks of
hyperviscosity in recipients.
Key issues
● All monochorionic (MC) twins have placental vascular ana-
stomoses allowing acute or chronic inter-twin blood trans-
fusion during pregnancy or during delivery.
● MC twins are at risk for severe complications such as twin-
twin transfusion syndrome (TTTS), twin anemia-polycythe-
mia sequence (TAPS) and acute peripartum TTTS.
● TTTS is characterized by oligohydramnios in the donor and
polyhydramnios in the recipient (TOPS).
● TAPS is characterized by chronic anemia in the donor and
polycythemia in the recipient without signs of TOPS during
pregnancy, and large inter-twin difference in hemoglobin
levels.
● Acute peripartum TTTS is characterized by large inter-twin
hemoglobin difference at birth without signs of TOPS dur-
ing pregnancy and without reticulocytosis in the donor.
● Differentiation between TAPS and acute peripartum TTTS
can be done by calculating the reticulocyte count ratio,
showing an increased ratio in TAPS as a sign of chronic
anemia in contrast to a low ratio in acute peripartum TTTS.
● Thrombocytopenia occurs frequently in recipient twins with
TAPS and is associated with hyperviscosity.
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